InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Buten Matthew. Insider active across 2 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 7 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €2m. Activity tracked since 31 December 2021. The latest transaction was filed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Buten Matthew is a declarant linked to Biohaven Ltd. and Biohaven Pharmaceutical Holding Co Ltd., where he is Chief Financial Officer. His 7 filings cover the period from 2022-01-04 to 2026-01-07, and, across the sampled recent filings, the stated amounts are EUR 1979538 of buys and EUR 932952 of sells, with Levée d'options as the most frequent transaction nature.